RENEE ADKINS: Open Payments
NPI 1942236377 · WESTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 42 payments from 11 companies in 2025. Trend: 2023 $793 · 2024 $985 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $199 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 12 | $139 |
| Novo Nordisk Inc | 7 | $137 |
| Actelion Pharmaceuticals US, Inc. | 1 | $112 |
| Kestra Medical Technology Services, Inc. | 1 | $83 |
| Amgen Inc. | 3 | $76 |
| PFIZER INC. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Chiesi USA, Inc. | 1 | $19 |
Products named: LEQVIO, LifeVest, Wegovy, UPTRAVI, Assure WCD, REPATHA, FARXIGA, JARDIANCE.
Industry payments across OH — which companies pay providers there.
